Circulating cell-free DNA levels are associated with adverse outcomes in heart failure : testing liquid biopsy in heart failure
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
European journal of preventive cardiology - 28(2021), 9 vom: 09. Aug., Seite e28-e31 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Salzano, Andrea [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cell-Free Nucleic Acids |
|---|
| Anmerkungen: |
Date Completed 04.04.2022 Date Revised 01.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1177/2047487320912375 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM307987159 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM307987159 | ||
| 003 | DE-627 | ||
| 005 | 20231225130752.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/2047487320912375 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1026.xml |
| 035 | |a (DE-627)NLM307987159 | ||
| 035 | |a (NLM)32212838 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Salzano, Andrea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Circulating cell-free DNA levels are associated with adverse outcomes in heart failure |b testing liquid biopsy in heart failure |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.04.2022 | ||
| 500 | |a Date Revised 01.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Cell-Free Nucleic Acids |2 NLM | |
| 700 | 1 | |a Israr, Muhammad Zubair |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia, Daniel Fernandez |e verfasserin |4 aut | |
| 700 | 1 | |a Middleton, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a D'Assante, Roberta |e verfasserin |4 aut | |
| 700 | 1 | |a Marra, Alberto M |e verfasserin |4 aut | |
| 700 | 1 | |a Arcopinto, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Yazaki, Yoshiyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Bernieh, Dennis |e verfasserin |4 aut | |
| 700 | 1 | |a Cassambai, Shabana |e verfasserin |4 aut | |
| 700 | 1 | |a Page, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Rengo, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Bossone, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Cittadini, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Shaw, Jacqueline A |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Toru |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of preventive cardiology |d 2012 |g 28(2021), 9 vom: 09. Aug., Seite e28-e31 |w (DE-627)NLM19817909X |x 2047-4881 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2021 |g number:9 |g day:09 |g month:08 |g pages:e28-e31 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/2047487320912375 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2021 |e 9 |b 09 |c 08 |h e28-e31 | ||